Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A0STSQ8
Thu, 24.11.2022
M1 Kliniken AG
Expansion of the Management Board of M1 Kliniken AG
Berlin, 24.11.2022 - The Supervisory Board of M1 Kliniken AG today appointed Mr. Attila Strauss to the Management Board of M1 Kliniken AG with immediate effect.
Mr. Strauss has already been a member of the Management Board of HAEMATO AG since April 1, 2022 and has contributed to a significant co [ … ]
Thu, 24.11.2022
M1 Kliniken AG
Expansion of the Management Board of M1 Kliniken AG
Berlin, 24.11.2022 - The Supervisory Board of M1 Kliniken AG today appointed Mr. Attila Strauss to the Management Board of M1 Kliniken AG with immediate effect.
Mr. Strauss has already been a member of the Management Board of HAEMATO AG since April 1, 2022 and has contributed to a significant co [ … ]
Tue, 15.11.2022
M1 Kliniken AG
Expansion of the Management Board of M1 Kliniken AG
Berlin, 15.11.2022 - At its meeting today, the Supervisory Board of M1 Kliniken AG appointed Mr. Kilian Brenske (28, MBA) to the management board of M1 Kliniken AG.
Mr Brenske has been working for the company for more than six years and during this time has managed and successfully developed all [ … ]
Tue, 15.11.2022
M1 Kliniken AG
Expansion of the Management Board of M1 Kliniken AG
Berlin, 15.11.2022 - At its meeting today, the Supervisory Board of M1 Kliniken AG appointed Mr. Kilian Brenske (28, MBA) to the management board of M1 Kliniken AG.
Mr Brenske has been working for the company for more than six years and during this time has managed and successfully developed all [ … ]
Mon, 14.11.2022
M1 Kliniken AG
M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market
Group turnover decreases to EUR 214 million (EUR 236 million as of Q3-2021)
Group EBITDA amounts to EUR 10.9 million (previous year: EUR 12.0 million); EBIT amounts to EUR 6.5 million (previous year: EUR 7.8 million)
Beauty [ … ]
Mon, 14.11.2022
M1 Kliniken AG
M1 Kliniken AG announces figures for Q3 2022: Group continues the expansion course with development of a new country market
Group turnover decreases to EUR 214 million (EUR 236 million as of Q3-2021)
Group EBITDA amounts to EUR 10.9 million (previous year: EUR 12.0 million); EBIT amounts to EUR 6.5 million (previous year: EUR 7.8 million)
Beauty [ … ]
Wed, 17.08.2022
M1 Kliniken AG
M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate
Group revenue falls to just under EUR 139 million (EUR 165 million in H1-2021)
Group EBITDA amounts to EUR 7.4 million (previous year: EUR 9.9 million); EBIT amounts to EUR 4.5 million (previous year: EUR 7.1 million)
Beauty [ … ]
Wed, 17.08.2022
M1 Kliniken AG
M1 Kliniken AG announces financials for H1-2022: positive business development despite cooling of general consumer climate
Group revenue falls to just under EUR 139 million (EUR 165 million in H1-2021)
Group EBITDA amounts to EUR 7.4 million (previous year: EUR 9.9 million); EBIT amounts to EUR 4.5 million (previous year: EUR 7.1 million)
Beauty [ … ]
Mon, 23.05.2022
M1 Kliniken AG
M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
- Group turnover falls to EUR 63.5 million (EUR 80.8 million in Q1-2021)
- Group EBITDA amounts to EUR 4.2 million (previous year: EUR 4.0 million); EBIT amounts to EUR 2.8 million (previous year: EUR 2.6 million)
- Beauty: In [ … ]
Wed, 04.05.2022
M1 Kliniken AG
Supervisory Board of M1 Kliniken AG adopts (consolidated) financial statements 2021 of M1 Kliniken AG. No deviations from the preliminary figures for financial year 2021 published at the end of March
- Supervisory Board adopts the 2021 annual financial statements of M1 Kliniken AG, which have been audited with unqualified audit opinions
- Turnove [ … ]